Symbols / CYPH $0.72 -8.78%
CYPH Chart
About
Cypherpunk Technologies Inc., a biopharmaceutical company, acquires and develops antibody therapies for the treatment of cancer. Its lead clinical stage drug candidate includes DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in various ongoing clinical trials for treating esophagogastric and gynecologic cancers, and colorectal cancer. The company also develops FL-501, a monoclonal antibody that inhibits GDF-15 protein that is in preclinical trial. It has an option and license agreement with Adimab, LLC and BeiGene, Ltd. to develop and commercialize DKN-01 in Asia (excluding Japan), Australia, and New Zealand. The company was formerly known as Leap Therapeutics, Inc. and changed its name to Cypherpunk Technologies Inc. in November 2025. The company was incorporated in 2011 and is based in Cambridge, Massachusetts.
Fundamentals
Scroll to Statements| Sector | Financial Services | Industry | Asset Management | Market Cap | 41.02M |
| Enterprise Value | 57.42M | Income | 4.82M | Sales | — |
| Book/sh | 1.83 | Cash/sh | 0.16 | Dividend Yield | — |
| Payout | 0.00% | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | 0.40 | P/C | — |
| EV/EBITDA | -1.56 | EV/Sales | — | Quick Ratio | 35.55 |
| Current Ratio | 35.56 | Debt/Eq | 0.03 | LT Debt/Eq | — |
| EPS (ttm) | -1.22 | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | 2026-05-13 | ROA | -21.61% |
| ROE | 5.11% | ROIC | — | Gross Margin | 0.00% |
| Oper. Margin | 0.00% | Profit Margin | 0.00% | Shs Outstand | 56.65M |
| Shs Float | 64.91M | Short Float | 26.13% | Short Ratio | 4.99 |
| Short Interest | — | 52W High | 3.70 | 52W Low | 0.22 |
| Beta | — | Avg Volume | 3.25M | Volume | 908.34K |
| Target Price | — | Recom | None | Prev Close | $0.79 |
| Price | $0.72 | Change | -8.78% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$0.70
Latest analyst target
3. DCF / Fair value
$-57.03
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.70
Low
—
High
—
Mean
—
- Cypherpunk Technologies (CYPH) Stock Forecast and Price Target 2026 - MarketBeat Wed, 18 Mar 2026 14
- Cypherpunk Technologies (CYPH) director converts 104,500 RSUs to 152,500 share stake - Stock Titan ue, 17 Mar 2026 22
- symbol__ Stock Quote Price and Forecast - CNN Sat, 15 Nov 2025 13
- CYPH.O Forecast — Price Prediction for 2026. Should I Buy CYPH.O? - Intellectia AI ue, 17 Mar 2026 11
- Cypherpunk Technologies (CYPH) director converts 168,750 RSUs into common shares - Stock Titan ue, 17 Mar 2026 21
- Cypherpunk (CYPH) director converts 168,750 RSUs into common stock - Stock Titan ue, 17 Mar 2026 21
- CYPH Should I Buy - Intellectia AI ue, 17 Mar 2026 11
- RSU settlements give Cypherpunk (CYPH) director 168,750 common shares - Stock Titan ue, 17 Mar 2026 21
- CYPH.O Technical Analysis & Stock Price Forecast - Intellectia AI Mon, 16 Mar 2026 07
- Director William Li of Cypherpunk (CYPH) receives 168,750 shares from RSU settlements - Stock Titan ue, 17 Mar 2026 22
- CYPH.O Earning Date, Earning Analysis and Earning Prediction - Intellectia AI ue, 17 Mar 2026 11
- Director Cavanaugh acquires 168,750 Cypherpunk (CYPH) shares from RSUs - Stock Titan ue, 17 Mar 2026 21
- Cypherpunk (CYPH) director converts 168,750 vested RSUs into common stock - Stock Titan ue, 17 Mar 2026 22
- Director Loscalzo acquires 168,750 Cypherpunk (CYPH) shares via RSUs - Stock Titan ue, 17 Mar 2026 21
- Director at Cypherpunk (CYPH) gains 168,750 shares via RSU settlements - Stock Titan ue, 17 Mar 2026 21
Insider Transactions
| Date | Shares | Url | Text | Insider | Position | Transaction | Start Date | Ownership | Value |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 83000 | — | — | DIETZ THOMAS JOHN | Director | — | 2025-12-26 00:00:00 | D | nan |
| 1 | 261840 | — | Sale at price 2.43 per share. | CAVANAUGH JAMES H | Director | — | 2025-11-17 00:00:00 | I | 636271.0 |
| 2 | 676319 | — | Sale at price 2.43 per share. | MIRABELLI CHRISTOPHER K | Director | — | 2025-11-17 00:00:00 | I | 1643455.0 |
| 3 | 676319 | — | Sale at price 2.43 per share. | ONSI DOUGLAS E | Chief Executive Officer | — | 2025-11-17 00:00:00 | I | 1643455.0 |
| 4 | 32500 | — | — | ONSI DOUGLAS E | Chief Executive Officer | — | 2025-03-28 00:00:00 | D | nan |
| 5 | 22500 | — | — | SIRARD CYNTHIA M.D. | Officer | — | 2025-03-28 00:00:00 | D | nan |
| 6 | 22500 | — | — | O'MAHONY JOHN MARK | Officer | — | 2025-03-28 00:00:00 | D | nan |
| 7 | 22500 | — | — | GRANFIELD CHRISTINE | Officer | — | 2025-03-28 00:00:00 | D | nan |
| 8 | 22500 | — | — | BAUM JASON | Officer | — | 2025-03-28 00:00:00 | D | nan |
| 9 | 22500 | — | — | LAWLOR AUGUSTINE | Chief Operating Officer | — | 2025-03-28 00:00:00 | D | nan |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | -8.82K | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.21 | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -70.01M | -85.92M | -53.77M | -40.16M |
| TotalUnusualItems | -42.00K | -1.00K | -608.00K | -379.00K |
| TotalUnusualItemsExcludingGoodwill | -42.00K | -1.00K | -608.00K | -379.00K |
| NetIncomeFromContinuingOperationNetMinorityInterest | -67.56M | -81.41M | -54.60M | -40.59M |
| ReconciledDepreciation | 5.00K | 15.00K | 16.00K | 29.00K |
| EBITDA | -70.05M | -85.92M | -54.38M | -40.54M |
| EBIT | -70.06M | -85.94M | -54.40M | -40.57M |
| NetInterestIncome | 3.13M | 4.03M | 871.00K | -32.00K |
| InterestExpense | 0.00 | 54.00K | 41.00K | |
| InterestIncome | 3.13M | 4.03M | 925.00K | 9.00K |
| NormalizedIncome | -67.52M | -81.41M | -53.99M | -40.21M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -67.56M | -81.41M | -54.60M | -40.59M |
| TotalExpenses | 70.06M | 85.94M | 54.71M | 41.70M |
| TotalOperatingIncomeAsReported | -70.06M | -87.04M | -56.76M | -41.43M |
| DilutedAverageShares | 37.55M | 20.45M | 11.32M | 8.58M |
| BasicAverageShares | 37.55M | 20.45M | 11.32M | 8.58M |
| DilutedEPS | -1.81 | -3.98 | -4.80 | -4.70 |
| BasicEPS | -1.81 | -3.98 | -4.80 | -4.70 |
| DilutedNIAvailtoComStockholders | -67.79M | -81.41M | -54.60M | -40.59M |
| NetIncomeCommonStockholders | -67.79M | -81.41M | -54.60M | -40.59M |
| OtherunderPreferredStockDividend | 234.00K | 0.00 | 0.00 | |
| NetIncome | -67.56M | -81.41M | -54.60M | -40.59M |
| NetIncomeIncludingNoncontrollingInterests | -67.56M | -81.41M | -54.60M | -40.59M |
| NetIncomeContinuousOperations | -67.56M | -81.41M | -54.60M | -40.59M |
| TaxProvision | 585.00K | 0.00 | 147.00K | -24.00K |
| PretaxIncome | -66.97M | -81.41M | -54.45M | -40.61M |
| OtherIncomeExpense | -42.00K | 499.00K | -608.00K | -379.00K |
| OtherNonOperatingIncomeExpenses | 500.00K | |||
| GainOnSaleOfSecurity | -42.00K | -1.00K | -608.00K | -379.00K |
| NetNonOperatingInterestIncomeExpense | 3.13M | 4.03M | 871.00K | -32.00K |
| InterestExpenseNonOperating | 0.00 | 54.00K | 41.00K | |
| InterestIncomeNonOperating | 3.13M | 4.03M | 925.00K | 9.00K |
| OperatingIncome | -70.06M | -85.94M | -54.71M | -40.20M |
| OperatingExpense | 70.06M | 85.94M | 54.71M | 41.70M |
| OtherOperatingExpenses | -1.10M | -2.05M | -1.23M | |
| ResearchAndDevelopment | 57.21M | 73.23M | 44.97M | 32.16M |
| SellingGeneralAndAdministration | 12.85M | 13.81M | 11.80M | 10.77M |
| GeneralAndAdministrativeExpense | 12.85M | 13.81M | 11.80M | 10.77M |
| OtherGandA | 12.85M | 13.81M | 11.80M | 10.77M |
| TotalRevenue | 0.00 | 0.00 | 0.00 | 1.50M |
| OperatingRevenue | 0.00 | 0.00 | 0.00 | 1.50M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| OrdinarySharesNumber | 38.33M | 25.57M | 9.90M | 8.83M |
| ShareIssued | 38.33M | 25.57M | 9.90M | 8.83M |
| TotalDebt | 266.00K | 262.00K | 678.00K | 469.00K |
| TangibleBookValue | 35.05M | 60.14M | 58.87M | 107.89M |
| InvestedCapital | 35.05M | 60.14M | 58.87M | 107.89M |
| WorkingCapital | 33.96M | 58.91M | 56.73M | 106.89M |
| NetTangibleAssets | 35.05M | 60.14M | 58.87M | 107.89M |
| CapitalLeaseObligations | 266.00K | 262.00K | 678.00K | 469.00K |
| CommonStockEquity | 35.05M | 60.14M | 58.87M | 107.89M |
| TotalCapitalization | 35.05M | 60.14M | 58.87M | 107.89M |
| TotalEquityGrossMinorityInterest | 35.05M | 60.14M | 58.87M | 107.89M |
| StockholdersEquity | 35.05M | 60.14M | 58.87M | 107.89M |
| GainsLossesNotAffectingRetainedEarnings | -120.00K | 106.00K | 128.00K | -267.00K |
| OtherEquityAdjustments | -120.00K | 106.00K | 128.00K | -267.00K |
| RetainedEarnings | -467.37M | -399.58M | -318.17M | -263.57M |
| AdditionalPaidInCapital | 502.50M | 459.59M | 376.90M | 371.64M |
| CapitalStock | 38.00K | 26.00K | 10.00K | 88.00K |
| CommonStock | 38.00K | 26.00K | 10.00K | 88.00K |
| PreferredStock | 0.00 | 0.00 | 0.00 | |
| TotalLiabilitiesNetMinorityInterest | 14.08M | 12.68M | 11.49M | 10.02M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 0.00 | 0.00 | 262.00K | 37.00K |
| PreferredSecuritiesOutsideStockEquity | 0.00 | 0.00 | ||
| LongTermDebtAndCapitalLeaseObligation | 0.00 | 262.00K | 37.00K | |
| LongTermCapitalLeaseObligation | 0.00 | 262.00K | 37.00K | |
| CurrentLiabilities | 14.08M | 12.68M | 11.22M | 9.99M |
| CurrentDebtAndCapitalLeaseObligation | 266.00K | 262.00K | 416.00K | 432.00K |
| CurrentCapitalLeaseObligation | 266.00K | 262.00K | 416.00K | 432.00K |
| PayablesAndAccruedExpenses | 13.81M | 12.42M | 10.81M | 9.55M |
| CurrentAccruedExpenses | 8.54M | 5.96M | 5.15M | 5.37M |
| Payables | 5.27M | 6.46M | 5.66M | 4.19M |
| TotalTaxPayable | 531.00K | 0.00 | ||
| IncomeTaxPayable | 531.00K | 0.00 | ||
| AccountsPayable | 4.74M | 6.46M | 5.66M | 4.19M |
| TotalAssets | 49.12M | 72.83M | 70.35M | 117.91M |
| TotalNonCurrentAssets | 1.08M | 1.23M | 2.40M | 1.04M |
| OtherNonCurrentAssets | 30.00K | 90.00K | ||
| NonCurrentPrepaidAssets | 823.00K | 966.00K | 1.11M | 293.00K |
| NonCurrentDeferredAssets | 0.00 | 576.00K | 159.00K | |
| NonCurrentDeferredTaxesAssets | 0.00 | 159.00K | ||
| NetPPE | 262.00K | 262.00K | 689.00K | 495.00K |
| AccumulatedDepreciation | -226.00K | -221.00K | -206.00K | -190.00K |
| GrossPPE | 488.00K | 483.00K | 895.00K | 685.00K |
| Leases | 331.00K | 326.00K | 738.00K | 69.00K |
| OtherProperties | 76.00K | 76.00K | 76.00K | 535.00K |
| MachineryFurnitureEquipment | 81.00K | 81.00K | 81.00K | 81.00K |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 48.04M | 71.60M | 67.95M | 116.87M |
| OtherCurrentAssets | 86.00K | 183.00K | 351.00K | 769.00K |
| PrepaidAssets | 769.00K | |||
| Receivables | 704.00K | 771.00K | 2.10M | 1.19M |
| OtherReceivables | 704.00K | 771.00K | 2.10M | 1.19M |
| CashCashEquivalentsAndShortTermInvestments | 47.25M | 70.64M | 65.50M | 114.92M |
| CashAndCashEquivalents | 47.25M | 70.64M | 65.50M | 114.92M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -60.30M | -43.75M | -49.04M | -35.16M |
| RepurchaseOfCapitalStock | 0.00 | -1.00K | 0.00 | |
| IssuanceOfCapitalStock | 40.00M | 0.00 | 0.00 | 97.22M |
| EndCashPosition | 47.25M | 70.64M | 65.50M | 114.92M |
| BeginningCashPosition | 70.64M | 65.50M | 114.92M | 52.07M |
| EffectOfExchangeRateChanges | -279.00K | -43.00K | -162.00K | -33.00K |
| ChangesInCash | -23.11M | 5.19M | -49.25M | 62.88M |
| FinancingCashFlow | 37.18M | -30.00K | -210.00K | 98.03M |
| CashFlowFromContinuingFinancingActivities | 37.18M | -30.00K | -210.00K | 98.03M |
| NetOtherFinancingCharges | -2.95M | -210.00K | -184.00K | |
| ProceedsFromStockOptionExercised | 133.00K | -29.00K | 0.00 | 997.00K |
| NetPreferredStockIssuance | 0.00 | |||
| PreferredStockIssuance | 0.00 | |||
| NetCommonStockIssuance | 40.00M | -1.00K | 0.00 | 97.22M |
| CommonStockPayments | 0.00 | -1.00K | 0.00 | |
| CommonStockIssuance | 40.00M | 0.00 | 0.00 | 97.22M |
| InvestingCashFlow | 0.00 | 48.97M | 0.00 | 0.00 |
| CashFlowFromContinuingInvestingActivities | 0.00 | 48.97M | 0.00 | 0.00 |
| NetOtherInvestingChanges | -1.39M | |||
| NetBusinessPurchaseAndSale | 0.00 | 50.36M | 0.00 | |
| SaleOfBusiness | 0.00 | 50.36M | 0.00 | |
| NetPPEPurchaseAndSale | 0.00 | |||
| SaleOfPPE | 0.00 | |||
| PurchaseOfPPE | 0.00 | |||
| OperatingCashFlow | -60.30M | -43.75M | -49.04M | -35.16M |
| CashFlowFromContinuingOperatingActivities | -60.30M | -43.75M | -49.04M | -35.16M |
| ChangeInWorkingCapital | 1.29M | 2.51M | -651.00K | 1.01M |
| ChangeInOtherWorkingCapital | 152.00K | -1.28M | ||
| ChangeInOtherCurrentLiabilities | -417.00K | -415.00K | -400.00K | -406.00K |
| ChangeInOtherCurrentAssets | 143.00K | 748.00K | -755.00K | 597.00K |
| ChangeInPayablesAndAccruedExpense | 1.46M | 712.00K | 945.00K | 3.90M |
| ChangeInPayable | 1.46M | 712.00K | ||
| ChangeInAccountPayable | 902.00K | 712.00K | ||
| ChangeInTaxPayable | 562.00K | 0.00 | ||
| ChangeInIncomeTaxPayable | 562.00K | 0.00 | ||
| ChangeInPrepaidAssets | 100.00K | 164.00K | 416.00K | -639.00K |
| ChangeInReceivables | 0.00 | 1.30M | -1.01M | -1.16M |
| OtherNonCashItems | 415.00K | 29.99M | 399.00K | 527.00K |
| StockBasedCompensation | 5.50M | 5.13M | 5.18M | 3.48M |
| DepreciationAmortizationDepletion | 5.00K | 15.00K | 16.00K | 29.00K |
| DepreciationAndAmortization | 5.00K | 15.00K | 16.00K | 29.00K |
| Depreciation | 5.00K | 15.00K | 16.00K | 29.00K |
| OperatingGainsLosses | 42.00K | 13.00K | 608.00K | 379.00K |
| NetForeignCurrencyExchangeGainLoss | 42.00K | 13.00K | 608.00K | 379.00K |
| GainLossOnSaleOfPPE | 392.00K | |||
| NetIncomeFromContinuingOperations | -67.56M | -81.41M | -54.60M | -40.59M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for CYPH
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|